Understanding Familial Hypercholesterolemia (FH)

Imagine a condition that silently clogs your arteries from the day you are born, regardless of how many salads you eat or miles you run. This is the reality for those living with Familial Hypercholesterolemia (FH), a genetic disorder that prevents the body from clearing LDL cholesterol from the blood.

Unless you test for it, FH is often "invisible". That is, until something dramatic, like a heart attack, occurs. The good news is that screening for FH is simple: a VERY high LDL level (more on that below) on a regular cholesterol profile is the first tip-off that you may have this condition.

What is the Mechanism of FH?

If you recall, high LDL cholesterol can be caused by three main factors. In simple terms, we make too much, we get rid of too little, or we don’t use enough. FH is a genetic inability to use enough, meaning that a person with FH has a really hard time clearing LDL from the circulation.

LDL is removed from the bloodstream by attaching to receptors on cells. The fewer the number of LDL receptors, or the lower their activity level, the higher the LDL.

There are three primary ways this happens:

1. LDLR Mutation: This is the most common cause (85-90%). The gene responsible for building LDL receptors is faulty, meaning there aren't enough receptors to bind LDL.
2. PCSK9 Mutation: PCSK9 is a protein that breaks down LDL receptors. This is especially helpful for removing old/less active ones. In some cases, people are born with very high PCSK9 levels, destroying the receptors before they can do their job.
3. ApoB Mutation: Apolipoprotein B is a protein that is present on every single LDL particle.  It acts as a key, locking the LDL particle into the receptor. If the key is misshapen, the receptor can’t grab the cholesterol.

Less and More Common Than You Think

A lot of people think that just because their LDL is high, it’s all caused by genetics. They may have even gone online and decided they have FH because their cholesterol has not changed much despite some lifestyle changes. 

Here’s an important fact you need to know: Not all high LDL is FH!  But all FH is accompanied by VERY high LDL. 

Based on genetic screening studies, it is estimated that FH affects approximately 1 in 311 people. That’s less than 0.5% of the population. Which means 99.5% of us have at least some potential to impact our cholesterol levels with strategic lifestyle – and especially nutrition - change.

Inheritance of this condition is autosomal dominant. So if one parent has FH, each child has a 50% chance of inheriting it.

Diagnosing Familial Hyperlipidemia

The diagnosis can be screened for with a standard blood test. We can also look for physical evidence. The definitive confirmatory test is genetic testing. 

1. Cholesterol Profile

This standard blood test is the first red flag. For adults, an LDL-C level ≥ 190 mg/dL suggests FH. For children, the threshold is typically ≥ 160 mg/dL. An important point to make here: Many women see their LDL shoot up after menopause. But just because it goes above 190 mg/dL all of a sudden, does not mean you have FH. LDL needs to be ≥190 mg/dL over most of a woman’s life, including before menopause, to raise suspicion of FH.

2. Physical Signs

While many have no symptoms, doctors can look for physical "clues" of cholesterol buildup:

• Xanthomas: Firm deposits of cholesterol on the Achilles tendons or knuckles.
• Corneal Arcus: A white or gray ring around the iris of the eye (significant if under age 45).
• Xanthelasma: Yellowish deposits around the eyelids.

3. Genetic Testing

Genetic testing is now the "gold standard" for confirmation. It involves sequencing the LDLR, PCSK9, and ApoB genes. Once a patient is identified as carrying one of these genetic markers, clinical guidelines recommend cascade testing - testing all first-degree relatives (parents, siblings, children) to catch the condition early.

Treating Familial Hypercholesterolemia

The 2026 ACC/AHA Cholesterol Guidelines have shifted toward more aggressive "lower for longer" goals to combat the cumulative damage of lifetime LDL exposure.  Here are the specific cholesterol goals for those with FH:

 

Patient Category	LDL-C Goal (2026 Guidelines)
FH alone (Primary Prevention)	< 70 mg/dL
FH with heart disease (High Risk)	< 55 mg/dL
Children with FH	< 100 mg/dL (starting as early as age 8–10)

 

Statins remain the mainstay of therapy – even for children. If people are unable to reach their cholesterol goal with statins alone, the guidelines advise adding ezetimibe and PCSK9 inhibitors as necessary. 

However, there is far more that can be done in addition to all those drugs! Lifestyle is central to ALL treatment efforts – for anyone with elevated cholesterol, and especially those with FH. A heart-healthy diet and exercise remain crucial to prevent additional risk factors like obesity or hypertension. They also help ensure that medications work at their peak potential – so that you need lower doses or fewer of them to get you to your cholesterol goal. 

I have seen plenty of patients who start with LDL levels ≥ 200 mg/dL and see dramatic reductions with Step One. I’ve also seen low dose statins with Step One yield eye popping results. Not everyone has a miraculous result, but you can test whether this intervention has the expected/hoped-for impact. Especially if you’re young and facing a lifetime of drug therapy.

Key Takeaways

1.      FH is relatively uncommon but requires aggressive cholesterol lowering if present.

2.      FH can be screened for effectively with a fasting cholesterol profile.

3.      An FH diagnosis should set off cascade screening of first degree relatives.

4.      FH is treatable with a combination of drugs and lifestyle.

5.      As for all patients with high cholesterol, lifestyle, and especially nutrition optimization, is critical to help reduce the lifetime burden of drug exposure.